Compare LONA & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LONA | GRWG |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | United States |
| Employees | 19 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.5M | 96.7M |
| IPO Year | N/A | 2015 |
| Metric | LONA | GRWG |
|---|---|---|
| Price | $10.01 | $1.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $10.00 | $2.50 |
| AVG Volume (30 Days) | 19.7K | ★ 311.5K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $193,365,479.00 |
| Revenue This Year | N/A | $5.09 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 142.51 |
| 52 Week Low | $4.21 | $0.96 |
| 52 Week High | $14.21 | $2.40 |
| Indicator | LONA | GRWG |
|---|---|---|
| Relative Strength Index (RSI) | 60.83 | 47.10 |
| Support Level | $8.06 | $1.43 |
| Resistance Level | $11.44 | $1.61 |
| Average True Range (ATR) | 0.77 | 0.07 |
| MACD | 0.15 | 0.01 |
| Stochastic Oscillator | 87.49 | 68.00 |
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
GrowGeneration Corp owns and operates specialty retail stores focused on hydroponic and organic gardening. The company markets and distributes nutrients, growing media, indoor and greenhouse lighting, ventilation systems, and related accessories. It operates through two reportable segments: Cultivation and Gardening, which includes its hydroponic and organic gardening business, and Storage Solutions, which includes its benching, racking, and storage solutions operations. The company generates revenue mainly from the sale of proprietary and non-proprietary products through retail stores, e-commerce platforms, wholesale distribution, and commercial sales, along with the sale and installation of commercial fixtures.